Eisai Co. Ltd.'s Fiscal Year is From April To March - All Figures are in JPY, Billions.
The item "Net-Interest-Income" stands at 2.26 Billion Japanese Yens for the trailing twelve months (TTM) period ending 12/31/2024, the lowest value since 06/30/2022.'
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -69.25 percent compared to the value the year prior.
The 1 year change in percent is -69.25.
The 3 year change in percent is 181.82.
The 5 year change in percent is -33.89.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Net Interest Income | 905,699,262,464.00 |
![]() | Johnson & Johnson - Net Interest Income | 486,508,953,600.00 |
![]() | AbbVie Inc - Net Interest Income | 399,570,305,024.00 |
![]() | Roche Holding AG - Net Interest Income | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Net Interest Income | 280,205,508,085.11 |